Announced on February 28 to mark Rare Disease Day, the initiative aims to streamline the transition from pediatric to adult care. While Sant Joan de Déu Hospital remains the leader in pediatrics, Bellvitge will now serve as the primary hub for adult patients facing these infrequent pathologies.
The Remma program involves 46 lead researchers and over 200 professionals from the Bellvitge Health Campus. They will focus on more than 390 rare conditions, including neurological, cardiovascular, and hereditary oncological diseases, utilizing advanced genomic tools to provide precision medicine.
“"We have been working in networks for rare diseases for 20 years, but this program will allow us to go faster and further."
